Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but Nov is dispensable for skeletal homeostasis

Endocrinology

Volumn 151, Issue 1, 2010, Pages 221-233

  Canalis, Ernesto ^a,b   Smerdel Ramoya, Anna ^a   Durant, Deena ^a   Economides, Aris N ^c   Beamer, Wesley G ^d   Zanotti, Stefano ^a  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; NEOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; C57BL 6 MOUSE; CALVARIA; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; FEMUR; GENE INACTIVATION; GENOTYPE; HOMEOSTASIS; HOMOLOGOUS RECOMBINATION; MALE; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SKELETON; STROMA CELL; SURFACE PLASMON RESONANCE; WILD TYPE;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG RESISTANCE; EMBRYO, MAMMALIAN; FEMALE; GENE SILENCING; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; OSTEOBLASTS; PROTEIN BINDING;

EID: 73649094137     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0574     Document Type: Article

References (55)

1. Brigstock DR 2003 The CCN family: a new stimulus package. J Endocrinol 178:169-175
2. Brigstock DR, Goldschmeding R, Katsube KI, Lam SC, Lau LF, Lyons K, Naus C, Perbal B, Riser B, Takigawa M, Yeger H 2003 Proposal for a unified CCN nomenclature. Mol Pathol 56:127-128
3. Garcia Abreu J, Coffinier C, Larraín J, Oelgeschläger M, De Robertis EM 2002 Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene 287:39-47
4. Abreu JG, Ketpura NI, Reversade B, De Robertis EM 2002 Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4:599-604
5. Rydziel S, Stadmeyer L, Zanotti S, Durant D, Smerdel-Ramoya A, Canalis E 2007 Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem 282:19762-19772
6. Smerdel-Ramoya A, Zanotti S, Stadmeyer L, Durant D, Canalis E 2008 Skeletal overexpression of connective tissue growth factor (CTGF) impairs bone formation and causes osteopenia. Endocrinology 149:4374-4381
7. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B 1992 Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12:10-21
8. Parisi MS, Gazzerro E, Rydziel S, Canalis E 2006 Expression and regulation of CCN genes in murine osteoblasts. Bone 38:671-677
9. Yu C, Le AT, Yeger H, Perbal B, Alman BA 2003 NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia. J Pathol 201:609-615
10. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY, Lau LF 2003 CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278:24200-24208
11. Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM, Lau LF 2005 Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem 280:8229-8237
12. Sakamoto K, Yamaguchi S, Ando R, Miyawaki A, Kabasawa Y, Takagi M, Li CL, Perbal B, Katsube K 2002 The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem 277:29399-29405
13. Fu CT, Bechberger JF, Ozog MA, Perbal B, Naus CC 2004 CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J Biol Chem 279:36943-36950
14. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E 2004 Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279:36931-36942
15. Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R 2000 Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151:931-944
16. Lafont J, Jacques C, Le Dreau G, Calhabeu F, Thibout H, Dubois C, Berenbaum F, Laurent M, Martinerie C 2005 New target genes for NOV/CCN3 in chondrocytes: TGF-β2 and type X collagen. J Bone Miner Res 20:2213-2223
17. Heath E, Tahri D, Andermarcher E, Schofield P, Fleming S, Boulter CA 2008 Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev Biol 8:18
18. Olson EN, Arnold HH, Rigby PW, Wold BJ 1996 Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85:1-4
19. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ 1996 Longrange disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA 93:13090-13095
20. Valenzuela DM, Murphy AJ, Frendewey D, Gale NW, Economides AN, AuerbachW,PoueymirouWT,Adams NC, Rojas J, Yasenchak J, Chernomorsky R, Boucher M, Elsasser AL, Esau L, Zheng J, Griffiths JA, Wang X, Su H, Xue Y, Dominguez MG, Noguera I, Torres R, Macdonald LE, Stewart AF, DeChiara TM, Yancopoulos GD 2003 High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21:652-659
21. Snaith MR, Natarajan D, Taylor LB, Choi CP, Martinerie C, Perbal B, Schofield PN, Boulter CA 1996 Genomic structure and chromosomal mapping of the mouse nov gene. Genomics 38:425-428
22. Narayanan K, Williamson R, Zhang Y, Stewart AF, Ioannou PA 1999 Efficient and precise engineering of a 200 kb β-globin human/ bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther 6:442-447
23. Yang XW, Model P, Heintz N 1997 Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat Biotechnol 15:859-865
24. Zhang Y, Buchholz F, Muyrers JP, Stewart AF 1998 A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20:123-128
25. Sauer B, Henderson N 1988 Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85:5166-5170
26. Nazarenko I, Lowe B, Darfler M, Ikonomi P, Schuster D, Rashtchian A 2002 Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore. Nucleic Acids Res 30:e37
27. Nazarenko I, Pires R, Lowe B, Obaidy M, RashtchianA2002 Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes. Nucleic Acids Res 30:2089-2195
28. O'Brien TP, Metallinos DL, Chen H, Shin MK, Tilghman SM 1996 Complementation mapping of skeletal and central nervous system abnormalities in mice of the piebald deletion complex. Genetics 143:447-461
29. Nagy TR, Prince CW, Li J 2001 Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats. J Bone Miner Res 16:1682-1687
30. Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN, Canalis E 2005 Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 146:655-665
31. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
32. McCarthy TL, Centrella M, Canalis E 1988 Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 3:401-408
33. Otsuka E, Yamaguchi A, Hirose S, Hagiwara H 1999 Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol 277:C132-C138
34. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S 1983 In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198
35. Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RG, Rodan GA, Reszka AA 1999 Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 96:133-138
36. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T2001 Duplexes of 21-nucleotide RNAs mediateRNAinterference in cultured mammalian cells. Nature 411:494-498
37. Sharp PA 2001 RNA interference-2001. Genes Dev 15:485-490
38. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G 1989 Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143-1147
39. Kouadjo KE, Nishida Y, Cadrin-Girard JF, Yoshioka M, St. Amand J 2007 Housekeeping and tissue-specific genes in mouse tissues. BMC Genomics 8:127
40. ZhaoM,QiaoM,Harris SE, OyajobiBO,MundyGR,ChenD2004 Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 279:12854-12859
41. Rowe PS, Garrett IR, Schwarz PM, Carnes DL, Lafer EM, Mundy GR, Gutierrez GE 2005 Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone 36:33-46
42. Wendler J, Vallejo LF, Rinas U, BilitewskiU2005 Application of an SPR-based receptor assay for the determination of biologically active recombinant bone morphogenetic protein-2. Anal Bioanal Chem 381:1056-1064
43. Crockett JC, Schütze N, Tosh D, Jatzke S, Duthie A, Jakob F, Rogers MJ 2007 The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of αvβ3 and αvβ5. Endocrinology 148:5761-5768
44. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML 2007 Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 22:1197-1207
45. BeamerWG,Donahue LR, Rosen CJ 2002 Genetics and bone. Using the mouse to understand man. J Musculoskelet Neuronal Interact 2:225-231
46. BeamerWG,Shultz KL, Ackert-Bicknell CL, Horton LG, Delahunty KM, Coombs 3rd HF, Donahue LR, Canalis E, Rosen CJ 2007 Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTL with sex dependent regulation of bone phenotypes. J Bone Miner Res 22:1187-1196
47. Bouxsein ML, Uchiyama T, Rosen CJ, Shultz KL, Donahue LR, Turner CH, Sen S, Churchill GA, Müller R, Beamer WG 2004 Mapping quantitative trait loci for vertebral trabecular bone volume fraction and microarchitecture in mice. J Bone Miner Res 19:587-599
48. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V 2006 BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38:1424-1429
49. Okamoto M, Murai J, Yoshikawa H, Tsumaki N 2006 Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 21:1022-1033
50. Smerdel-Ramoya A, Zanotti S, Deregowski V, Canalis E 2008 Connective tissue growth factor enhances osteoblastogenesis in vitro. J Biol Chem 283:22690-22699
51. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM 2003 Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779-2791
52. Kutz WE, Gong Y, Warman ML 2005 WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice. Mol Cell Biol 25:414-421
53. MoFE, MunteanAG,Chen CC, Stolz DB, Watkins SC, Lau LF 2002 CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 22:8709-8720
54. French DM, Kaul RJ, D'Souza AL, Crowley CW, BaoM, Frantz GD, Filvaroff EH, Desnoyers L 2004 WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 165:855-867
55. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, Jiang W, Luo X, Li X, Yin H, Montag AG, Haydon RC, He TC 2006 CCN1/ Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26:2955-2964